Ayaka Kobayashi

Metabolic phenotypes and incident type 2 diabetes: Population‐based Panasonic cohort study 6

M. Fukui, M. Hamaguchi, Hiroshi Okada, 2022, Obesity.

Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db Mice

M. Fukui, E. Ushigome, M. Hamaguchi, 2022, Nutrients.

Randomized Controlled Trial of Simple Salt Reduction Instructions by Physician for Patients with Type 2 Diabetes Consuming Excessive Salt

M. Fukui, E. Ushigome, C. Oyabu, 2021, International Journal of Environmental Research and Public Health.

Leucine and Glutamic Acid as a Biomarker of Sarcopenic Risk in Japanese People with Type 2 Diabetes

M. Fukui, E. Ushigome, M. Hamaguchi, 2023, Nutrients.

Daidzein Inhibits Muscle Atrophy by Suppressing Inflammatory Cytokine- and Muscle Atrophy-Related Gene Expression

M. Fukui, M. Hamaguchi, Saori Majima, 2024, Nutrients.